<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: We investigated the therapeutic possibilities of gamma brachytherapy to improve the final functional results of eyes with choroidal <z:hpo ids='HP_0001028'>hemangiomas</z:hpo>, which are <z:e sem="disease" ids="C1377916" disease_type="Neoplastic Process" abbrv="">benign vascular tumors</z:e> that can induce progressive impairment of visual acuity </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We treated 41 patients with choroidal <z:hpo ids='HP_0001028'>hemangioma</z:hpo> with <z:chebi fb="240" ids="27638">cobalt</z:chebi>-60 applicators </plain></SENT>
<SENT sid="2" pm="."><plain>The lesions consisted of 39 circumscribed <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> and two diffuse <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> in patients with <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Before treatment, visual acuity in the affected eye was 20/200 in ten patients, 20/200 to 20/50 in 17 patients, 20/40 to 20/25 in 11 patients, and 20/20 in three patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were symptomatic </plain></SENT>
<SENT sid="5" pm="."><plain>The macula was infiltrated by the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> in 12 eyes (29.3%) </plain></SENT>
<SENT sid="6" pm="."><plain>There was <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> in 40 eyes (97.6%), cystoid <z:hpo ids='HP_0000969'>edema</z:hpo> in ten eyes (24.4%), subretinal <z:mp ids='MP_0003045'>fibrosis</z:mp> in eight eyes (19.5%), and areolar <z:mpath ids='MPATH_127'>atrophy</z:mpath> in two eyes (4.9%) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: After treatment, the retina was reattached in <z:hpo ids='HP_0000001'>all</z:hpo> eyes, and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> progressively transformed into a flat scar </plain></SENT>
<SENT sid="8" pm="."><plain>The postirradiation macular lesions that we identified were pigment migrations in the macular region, subretinal <z:mp ids='MP_0003045'>fibrosis</z:mp>, and an areolar atrophic scar </plain></SENT>
<SENT sid="9" pm="."><plain>We correlated the functional results at two, five, and ten years after treatment with the initial visual acuity, and with pre-existing and posttreatment macular lesions </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our results suggest that radiotherapy is a valuable therapeutic modality for choroidal <z:hpo ids='HP_0001028'>hemangiomas</z:hpo>, particularly in <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> that involve the macula, and for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> associated with bullous <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> </plain></SENT>
</text></document>